Trial
NCT01104298
Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Grupo Espanol de Investigacion en Sarcomas
Collaborators
—
Condition
Sarcoma
Intervention
Doxorubicin
Why stopped
Interim analysis did not show good results for main objective
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-10-27